Cognex Corporation (CGNX) — Fair Value Analysis
Base-case fair value (P50): $48.57 · Current price: $60.82 · Verdict: Overvalued
The Verdict on CGNX
COGNEX CORP (CGNX) is currently marked as Overvalued by our Monte Carlo simulations. The models indicate a median fair value ($48.57) that sits significantly below the current trading price of $60.82. This analysis suggests a potential -20.1% downside based on the most probable outcomes from thousands of forward-looking scenarios. The discrepancy between the market's assessment and our quantitative models points to elevated risk for new positions at these levels. Investors should exercise caution, as CGNX's underlying financial and operational health, while average, does not fully support the current market valuation.
How CGNX stacks up against peers
CGNX's operational and financial health is categorized as "average" relative to its sector peers. This average quality tier suggests that while the company isn't facing severe distress, it also doesn't possess extraordinary competitive advantages or superior financial performance that would justify a substantial premium. Our Monte Carlo models factor in these comparative strengths and weaknesses, leading to a median fair value of $48.57. When comparing $60.82 to this intrinsic valuation, CGNX appears less attractive than similarly-tiered companies with more favorable risk-reward profiles. The -20.1% gap reinforces this perspective, highlighting a disconnect from fundamental drivers.
What this means for investors
For investors eyeing COGNEX CORP, the current Monte Carlo analysis flags a notable overvaluation. With $60.82 trading above the median fair value of $48.57, and an indicated -20.1% gap, the immediate outlook suggests a higher degree of risk. While bull case scenarios are always possible, the average quality tier of CGNX against its sector provides little fundamental support for sustained higher multiples. Investors seeking to capitalize on mispricings might find more compelling opportunities elsewhere or consider waiting for a more attractive entry point. For a complete understanding of the potential downside and upside distribution, including bear and bull targets and probability assessments, sign up for a free FairCurve account.
Frequently Asked Questions
Is CGNX overvalued or undervalued right now?
Based on our Monte Carlo simulations, CGNX is currently overvalued, with its current price of $60.82 trading above the median fair value of $48.57.
What is the bear case and bull case for CGNX?
The full Monte Carlo distribution, including bear (P10) and bull (P90) targets, alongside the probability of achieving upside, is exclusively available to users with a free FairCurve account.
How does FairCurve calculate CGNX's fair value?
FairCurve calculates CGNX's fair value through a sophisticated Monte Carlo simulation process, projecting thousands of forward scenarios to determine a probabilistic range of intrinsic values.
How can I track CGNX's fair value as it changes?
You can track CGNX's fair value by adding it to your free FairCurve watchlist, which provides daily updates and instant re-valuations when new earnings or significant fundamental data are released.